raremaprare-disease reference indexOrphadata 2026-06-23 · HPO 2026-09-01
ORPHA:542301

EBV-induced lymphoproliferative disease due to CARMIL2 deficiency

Synonyms: EBV-induced lymphoproliferative disease due to capping protein regulator and myosin 1 linker 2 deficiency

Type
Disease
Group
Disorder
Inheritance
Autosomal recessive
Age of onset
Childhood
Status
active

A rare immune dysregulation disease with immunodeficiency characterized by infantile or childhood onset of a variable phenotype including recurrent/persistent bacterial, fungal, and viral infections with involvement of the skin, lower respiratory tract, and gastrointestinal tract, eczema, allergies, and inflammatory bowel disease, among others. EBV-related smooth muscle tumors have also been reported. Immunophenotyping shows decreased Treg counts, as well as a deficient CD3/CD28 co-stimulation response in CD4+ and CD8+ T-cells.

1

Names in Orphadata languages

12 of 12 languages
LangNameSynonyms
enEBV-induced lymphoproliferative disease due to CARMIL2 deficiencyEBV-induced lymphoproliferative disease due to capping protein regulator and myosin 1 linker 2 deficiency
frMaladie lymphoproliférative associée à l'EBV par déficit en CARMIL2Maladie lymphoproliférative associée au virus Epstein-Barr par déficit en protéine capping protein regulator and myosin 1 linker 2
deEBV-induzierte lymphoproliferative Krankheit durch CARMIL2-MangelCARMIL2-Defizienz
esEnfermedad linfoproliferativa inducida por EBV por deficiencia de CARMIL2Enfermedad linfoproliferativa inducida por EBV por deficiencia del regulador de la proteína de 'capping' y conector de miosina 1 tipo 2
itMalattia linfoproliferativa indotta da EBV da deficit di CARMIL2Malattia linfoproliferativa indotta da EBV da deficit del regolatore della proteina capping e del linker 2 della miosina 1
nlEBV-geïnduceerde lymfoproliferatieve ziekte door CARMIL2-deficiëntieEBV-geïnduceerde lymfoproliferatieve ziekte door deficiëntie van 'capping protein regulator and myosin 1 linker 2'
ptImunodeficiência combinada por deficiência CARMIL2Imunodeficiência combinada por deficiência RLTPR
plCiężki złożony niedobór odporności z powodu deficytu CARMIL2Ciężki złożony niedobór odporności z powodu niedoboru RLTPR
csZávažná kombinovaná imunodeficience způsobená deficitem CARMIL2Závažná kombinovaná imunodeficience způsobená deficitem RLTPR
ukКомбінований імунодефіцит внаслідок дефіциту CARMIL2Комбінований імунодефіцит внаслідок дефіциту RLTPR
zhCARMIL2基因缺陷诱导的重症联合型免疫缺陷病RLTPR基因缺陷诱导的重症联合型免疫缺陷病
trCARMIL2 eksikliğine bağlı ağır kombine immün yetmezlikRLTPR eksikliğine bağlı ağır kombine immün yetmezlik

Definition in:

2

Cross-references

qualifier = Orphanet mapping relation
SourceCodeQualifierICD relationValidation
OMIM618131Evalidated
ICD-10D82.3NTBTattributedvalidated
MONDO0029134Evalidated
MONDO29134Evalidated
UMLSC5568557Evalidated

E exact · NTBT this ORPHAcode is narrower than the target · BTNT broader than the target · ND not decided.

3

Classification

Preferential parent (Orphanet linearisation):

Parents in the classifications (4):

No children.

4

Genes

1 direct
GeneAssociationStatusHGNCEnsemblOMIMLocusNameSource of validation
CARMIL2Disease-causing germline mutation(s) inAssessedHGNC:27089ENSG0000015975361085916q22.1capping protein regulator and myosin 1 linker 229226302[PMID]_27896283[PMID]
5

Prevalence and incidence

2 records
TypeClassValueAreaQualificationValidationSource
Cases/families21 casesWorldwideCase(s)Validated27896283[PMID]_27647349[PMID]_28112205[PMID]_29479355[PMID]
Point prevalence<1 / 1 000 000—WorldwideClass onlyValidatedORPHANET_27896283[PMID]_27647349[PMID]_28112205[PMID]_29479355[PMID]

Value is Orphadata's ValMoy: the mean estimate per 100 000 for prevalence and incidence, the number of cases or families for case reports.

6

HPO phenotypes

Orphanet has no HPO annotation for this code in this release.

7

Sources for this card